USA flag logo/image

An Official Website of the United States Government

A novel breast scaffold

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
95865
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
CA141727
Solicitation Year:
N/A
Solicitation Topic Code:
NCI
Solicitation Number:
N/A
Small Business Information
BIOSTRUXS, LLC
5021 ROYAL VISTA COURT WESTLAKE VILLAGE, CA 91362-5609
View profile »
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: A novel breast scaffold
Agency: HHS
Contract: 1R43CA141727-01A2
Award Amount: $151,800.00
 

Abstract:

DESCRIPTION (provided by applicant): The most common malignancy in American women is breast cancer. Breast reconstruction for mastectomy currently involves two choices, implant or autologous tissue flap. Implant reconstruction is relatively simpler but is temporary, whereas flap reconstruction is permanent but much more complex. We propose here a novel method for breast reconstruction by implanting a novel three dimensional biodegradable scaffold. This scaffold is designed to accommodate the patient's own omentum and fat tissues. Over time, the scaffold would be completely resorbed, leaving the patient's autologous tissue in the form of a new breast. Our specific aims are as follows: 1) to construct prototypes of the biodegradable scaffold, and 2) to test t he prototypes in pigs. PUBLIC HEALTH RELEVANCE: We propose a novel method for breast reconstruction after mastectomy for breast cancer. Current reconstruction involves two choices, implant or autologous tissue flap. Implant reconstruction is relativ ely simpler but is temporary, whereas flap reconstruction is permanent but much more complex. Complications in implant breast reconstruction are 2-3 folds higher than in breast augmentation, and the typical implant only lasts a few years. Flap reconstructi on operations take several hours; require a hospital stay of approximately 4-5 days and subsequent outpatient rehabilitation of approximately 4-6 weeks. The patient then has one or more permanent large scar(s) at the donor site(s). Our novel method would a chieve the long-term benefits of autologous tissue transfer with much less operative morbidity than the current flap reconstruction.

Principal Investigator:

James Watson
DRJAMESPWATSON@GMAIL.COM

Business Contact:

Craig Brooks
Small Business Information at Submission:

BIOSTRUXS, LLC
5021 ROYAL VISTA COURT WESTLAKE VILLAGE, CA 91362

EIN/Tax ID: 126471180
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No